Results 191 to 200 of about 16,846 (220)

MEDROXYPROGESTERONE ACETATE AND HOMOZYGOUS SICKLE-CELL DISEASE

Lancet, The, 1982
Richard Hayes
exaly  

Medroxyprogesterone

Reactions Weekly, 2010
openaire   +1 more source

Medroxyprogesterone

Reactions Weekly, 1990
openaire   +2 more sources

Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate

Fertility and Sterility, 2006
M Kathleen Clark, Maryfran Sowers, Barcey T Levy   +2 more
exaly  

Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone

American Journal of Obstetrics and Gynecology, 1994
J Donald Woodruff, James H Pickar
exaly  

Medroxyprogesterone

Reactions Weekly
  +5 more sources

Randomized clinical trial of self versus clinical administration of subcutaneous depot medroxyprogesterone acetate

Contraception, 2014
Katharine O'Connell White, Serge Cremers, Carolyn L Westhoff   +2 more
exaly  

MEDROXYPROGESTERONE

2004
openaire   +1 more source

Medroxyprogesterone

Reactions, 1988
openaire   +1 more source

Implanon® versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis — a pilot study

Contraception, 2009
Katharina Walch, Christine Kurz, Elisabeth Pernicka   +2 more
exaly